Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |